基于结构和连接体的设计,用于识别针对5-LOX的高强度分子
Rajbir Kaur1, Sudesh Rani1, Palwinder Singh1
1Department of Chemistry, UGC Sponsored Centre for Advanced Studies, Guru Nanak Dev University, Amritsar 143005, India.
Bioorganic & medicinal chemistry letters
|August 17, 2023
概括
新的二甲氧醇分子显示出强大的5-氧基酶 (5-LOX) 抑制. 这些通过分子建模设计的化合物具有可调节的特性和具有竞争力的结合,为炎症疾病提供了潜在的治疗方法.
科学领域:
- 药用化学 医学化学
- 酶抑制可以抑制酶.
- 药物发现 药物发现 药物发现
背景情况:
- 炎症性疾病通常与像5-lipoxygenase (5-LOX) 这样的酶的活性有关.
- 现有的抑制剂,如 zileuton 与5-LOX活性部位相互作用,该活性部位也与酸 (AA) 结合.
研究的目的:
- 设计和合成针对5-LOX酶的新型小分子.
- 研究这些分子对5-LOX的结合模式和抑制潜力.
- 评估合成化合物对潜在治疗应用的类似药物的特性.
主要方法:
- 基于5-LOX与阿拉基酸和zileuton的结合分析的分子建模.
- 合成二甲替代的氧醇衍生物,标有醇/醇部分.
- 在体外评估5-LOX抑制活性,水溶性,人血清白蛋白结合和代谢稳定性.
主要成果:
- 合成了基于oxindole的新型分子,能够访问5-LOX活性部位.
- 化合物在亚微分子范围内表现出显著的5-LOX抑制活性.
- 迈凯利斯-门分析证实了设计分子对5-LOX的竞争性抑制.
结论:
- 该研究成功地确定了具有强大5-LOX抑制活性的有希望的小分子.
- 在pyrrole/indole-N的衍生允许调制物理化学性质.
- 这些化合物代表了开发新型抗炎疗法的潜在候选者.
更多相关视频
10:49Method to Visualize and Analyze Membrane Interacting Proteins by Transmission Electron Microscopy
Published on: March 5, 2017
13.3K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.2K
相关概念视频
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Structure-Activity Relationships and Drug Design
768
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
768
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
